Get started
Author

Marco J.J.H. Grootenboers

Observed names: Grootenboers, M J J H, M. Grootenboers, M. J. J. H. Grootenboers, M.J.J.H Grootenboers, M.J.J.H. Grootenboers, Marco J. J. H. Grootenboers, Marco JJH Grootenboers
OpenAlex ID: A5108739147
Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism
2014 · Marc Righini, Josien Van Es, et al. · JAMA · 961
PDF
Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series
2020 · Antine W. Flikweert, Marco J.J.H. Grootenboers, et al. · Journal of Critical Care · 98
No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis
2017 · Caroline E. Broos, Linda H.C. Poell, et al. · Respiratory Medicine · 85
Isolated Lung Perfusion With Melphalan for Resectable Lung Metastases: A Phase I Clinical Trial
2004 · Jeroen M.H. Hendriks, Marco J.J.H. Grootenboers, et al. · The Annals of Thoracic Surgery · 72
Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis
2018 · Caroline E. Broos, Monique Wapenaar, et al. · European Respiratory Journal · 63
PDF
Circulating adipokine levels and COVID-19 severity in hospitalized patients
2022 · Antine W. Flikweert, Anneke C. Muller Kobold, et al. · International Journal of Obesity · 37
PDF
Isolated lung perfusion for pulmonary metastases, a review and work in progress
2006 · Marco JJH Grootenboers, Jos Heeren, et al. · Perfusion · 22
Re-Evaluation of Toxicity and Long-Term Follow-Up of Isolated Lung Perfusion With Melphalan in Patients With Resectable Pulmonary Metastases: A Phase I and Extension Trial
2007 · Marco J.J.H. Grootenboers, Franz M.N.H. Schramel, et al. · The Annals of Thoracic Surgery · 16
PDF
Selective pulmonary artery perfusion followed by blood flow occlusion: New challenge for the treatment of pulmonary malignancies
2008 · Marco J.J.H. Grootenboers, Franz M.N.H. Schramel, et al. · Lung Cancer · 14
Lupus anticoagulant associates with thrombosis in patients with COVID‐19 admitted to intensive care units: A retrospective cohort study
2022 · Tessa Noordermeer, Roger E.G. Schutgens, et al. · Research and Practice in Thrombosis and Haemostasis · 12
PDF
Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease
2021 · Sander Talman, Sevim Uzun, et al. · International Journal of COPD · 9
PDF
Ruling out Pulmonary Embolism in Patients with (Suspected) COVID-19—A Prospective Cohort Study
2021 · Milou A.M. Stals, Fleur H.J. Kaptein, et al. · TH Open · 8
PDF
Impact of low-dose chest computed tomography and multiplex PCR on antibiotic usage for community-acquired pneumonia: multicentre prospective controlled before–after study with cluster randomization
2026 · Lufang Zhang, Roel M. Aleva, et al. · Clinical Microbiology and Infection · 2
Methotrexate Versus Prednisone as First-Line Treatment for Pulmonary Sarcoidosis: The PREDMETH Trial
2025 · V. Kahlmann, M. Veltkamp, et al. · American Journal of Respiratory and Critical Care Medicine · 2
A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study
2026 · E.S.L. Martens, B. Akerboom, et al. · Thrombosis Research · 1
Effect of methotrexate and prednisone on intermediate monocytes in pulmonary sarcoidosis
2025 · Montse Janssen Bonás, C. Benschop-Roodenburg, et al. · 1
Assessing differential application of thromboprophylaxis regimes related to risk of pulmonary embolism and mortality in COVID-19 patients through instrumental variable analysis
2025 · Linda Nab, Chantal Visser, et al. · Scientific Reports · 1
Long-term response to prednisone in newly treated patients with pulmonary sarcoidosis
2021 · Vivienne Kahlmann, Catharina C. Moor, et al. · 1
A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study
2026 · E.S.L. Martens, B. Akerboom, et al. · medRxiv
PDF
Prospective measurements of sIL2R concentrations in a cohort of pulmonary sarcoidosis
2025 · Montse Janssen Bonás, V. Kahlmann, et al.
Patient experiences with an online home monitoring program for sarcoidosis
2025 · Astrid Dunweg, V Kahlmann, et al.
Correlation Between Methotrexate Polyglutamates Concentrations in Red Blood Cells and Pulmonary Function in Patients Treated With Methotrexate in the PREDMETH Trial
2025 · M. Janssen Bonás, J. Sundaresan, et al. · American Journal of Respiratory and Critical Care Medicine
Age-AdjustedD-DimerCutoffLevels toRuleOutPulmonaryEmbolism The ADJUST-PE Study
2014 · Marc Righini, Josien van Es, et al.
Regional Chemotherapy of the Lung: Investigations of Isolated Lung Perfusion and Selective Pulmonary Artery Perfusion
2008 · Marco J.J.H. Grootenboers · Utrecht University Repository (Utrecht University)
A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.
· Martens, E S L, Akerboom, B, et al. · Open Access CRIS of the University of Bern
Works count: 25
Citation count: 1,405
H-index: 10
I10-index: 10
Year
Topic
Type